Browse All

Current Filters

CLEAR FILTER x

TITLE

Tracking Daily Impact of Generalized Myasthenia Gravis Using Smartphone-Based Digital Biomarkers: Lessons Learned from a 1-Year Study with ME&MGopen

Author:Barnett-Tapia, Carolina   Lehnerer, Sophie   Carment, Loic   Gorin, Clarissa   Ravindra, Dellini   Sellami, Noura   Dutta, Bhaskar   Zinaï, Saad   Howard, James   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Preclinical Studies, Drug Safety, and Health Economics  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.030  

Author Institution:Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and HumboldtUniversität zu Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117 Berlin, Germany, Berlin, Germany  Ad Scientiam, Paris, France, Paris, France  Alexion Pharmaceuticals Inc., Winchester, MA  

Unveiling Disparities in AANHPI: A Comprehensive Analysis of Etiology, Presentation, and Treatment in Peripheral Neuropathy

Author:Cheung, Anita   Kim, Lauren   Kim, Jiwoo   Wright, D-Dre   Nakamura, Ryan   Matsunaga, Masako   Carrazana, Enrique   Liow, Kore   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Preclinical Studies, Drug Safety, and Health Economics  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.031  

Author Institution:University of Hawaii John A Burns School of Medicine, Honolulu, HI  

Evaluation of the Indirect and Nonmedical Impacts of Generalized Myasthenia Gravis on Patients and Caregivers

Author:Gwathmey, Kelly   Yee, Karen   Foss, Allison   Ramirez, Christina   Sullivan, Jamie   dosReis, Susan   Thiele, Craig   Schwartz, Taylor   Betor, Nicole   Hunt, Olivia   Rebeira, Mayvis   Narayanaswami, Pushpa   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Preclinical Studies, Drug Safety, and Health Economics  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.032  

Author Institution:VCU Health, Richmond, VA  Alexion, AstraZeneca Rare Disease, Boston, MA  Myasthenia Gravis Association, Kansas City, MO  Patient Consultant, Rogers, AR  The EveryLife Foundation for Rare Diseases, Washington, DC  University of Maryland School of Pharmacy, Baltimore, MD  Health Management Associates (subcontractor), Dayton, OH  Avalere, Washington, DC  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA  

Length of Hospital Stay in Patients with Guillain-Barré Syndrome Treated in Urban Versus Rural Hospitals

Author:Davies, Devin   Bhandal, Deap   Tuschhoff, Justin   Vallejo, Julian   Joseph, Jeffrin   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Preclinical Studies, Drug Safety, and Health Economics  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.033  

Author Institution:University of Missouri-Kansas City School of Medicine, St. Joseph, MO  

Economic Burden of Myasthenia Gravis Exacerbation and Crisis from US Payer Perspective

Author:Labson, Daniel   Cai, Qian   Gandhi, Kavita   Ait-Tihyaty, Maria   Nikolaou, Andreas   Kwong, Winghan Jacqueline   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Preclinical Studies, Drug Safety, and Health Economics  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.034  

Author Institution:Janssen Global Services, Health Economics & RWE, USA, Titusville, NJ